Gene · 9476
Papers2,888
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
261 to 280 of 2,888
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Ensartinib is effective in the treatment of advanced non-small-cell lung cancer with MET amplification after multi-line ALK-TKIs resistance: a case report. | Anticancer Drugs | 2024 | 38179893 | PubTator, text mining | PubMed |
| Robotic-assisted right upper lobectomy with systemic pulmonary vein anomaly: a case report. | J Cardiothorac Surg | 2024 | 38173007 | PubTator, text mining | PubMed |
| Lung adenocarcinoma metastasis within a pituitary neuroendocrine tumor: a case report with review of literature. | Endocr J | 2024 | 38171721 | PubTator, text mining | PubMed |
| Bronchogenic cysts in rare sites (retroperitoneum, skin, spinal cord and pericardial cavity): A case series and characterization of epithelial phenotypes. | Biomed Rep | 2024 | 38170018 | PubTator, text mining | PubMed |
| [A Case of New Rapidly Progressing Ground-glass Nodule Lung Adenocarcinoma Near Primary Lesion after Stereotactic Body Radiation Therapy]. | Zhongguo Fei Ai Za Zhi | 2024 | 38163982 | PubTator, text mining | PubMed |
| A case of primary lung adenocarcinoma mimicking metastatic papillary thyroid carcinoma. | Thorac Cancer | 2024 | 38131508 | PubTator, text mining | PubMed |
| Clinicopathological characteristics and treatment outcomes of advanced SMARCA4-deficient thoracic tumors. | Cancer Med | 2024 | 38124509 | PubTator, text mining | PubMed |
| Long‑term survival of a patient with advanced lung cancer treated with targeted therapy and anti‑PD‑1 immunotherapy as multi‑line therapy: A case report. | Oncol Lett | 2024 | 38108071 | PubTator, text mining | PubMed |
| Pulmonary cryptococcosis coexisting with lung adenocarcinoma: A case report and review of the literature. | Oncol Lett | 2024 | 38106523 | PubTator, text mining | PubMed |
| Clinicopathological analysis of bronchiolar adenoma combined with lung adenocarcinoma: Report of eight cases and literature review. | Histol Histopathol | 2024 | 38059279 | PubTator, text mining | PubMed |
| Human Pluripotent Stem Cell-Derived Alveolar Organoids: Cellular Heterogeneity and Maturity. | Tuberc Respir Dis (Seoul) | 2024 | 37993994 | PubTator, text mining | PubMed |
| Clear Cell Adenocarcinoma of Urethra: Clinical and Pathologic Implications and Characterization of Molecular Aberrations. | Cancer Res Treat | 2024 | 37697729 | PubTator, text mining | PubMed |
| Complete response of a locally advanced pulmonary hepatoid adenocarcinoma patient to perioperative XELOX-containing chemoimmunotherapy. | Genes Dis | 2024 | 37588195 | PubTator, text mining | PubMed |
| Immunohistochemical Characterization of a Large Cohort of Triple Negative Breast Cancer. | Int J Surg Pathol | 2024 | 37306115 | PubTator, text mining | PubMed |
| Nonbacterial Thrombotic Endocarditis Caused by Early-stage Lung Cancer: An Autopsy Case Report. | Intern Med | 2024 | 37164662 | PubTator, text mining | PubMed |
| Atypical Endometriosis: Comprehensive Characterization of Clinicopathologic, Immunohistochemical, and Molecular Features. | Int J Gynecol Pathol | 2024 | 37043650 | PubTator, text mining | PubMed |
| Primary salivary duct carcinoma of the lung: clinicopathological features, diagnosis and practical challenges. | J Clin Pathol | 2024 | 36697219 | PubTator, text mining | PubMed |
| Pulmonary sclerosing pneumocytoma: A potential pitfall mimicking lung adenocarcinoma. | GHM Open | 2023 | 40143840 | PubTator, text mining | PubMed |
| Pathological complete response to neoadjuvant therapy with serplulimab and chemotherapy in stage IIIB small cell lung cancer: a case report and literature review. | Front Immunol | 2023 | 38304254 | PubTator, text mining | PubMed |
| Epigenetic mechanisms of particulate matter exposure: air pollution and hazards on human health. | Front Genet | 2023 | 38299096 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/9476/papers?page=14